Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.

[1]  D. Mancini,et al.  Fracture after cardiac transplantation: a prospective longitudinal study. , 1996, The Journal of clinical endocrinology and metabolism.

[2]  R. Marcus,et al.  Correlates of osteopenia in patients with cystic fibrosis. , 1996, Pediatrics.

[3]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  S. Barbagallo,et al.  Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. , 1995, The American journal of medicine.

[5]  P. Delmas,et al.  Bone loss after orthotopic liver transplantation. , 1994, The American journal of medicine.

[6]  R. Henderson,et al.  Kyphosis and fractures in children and young adults with cystic fibrosis. , 1994, The Journal of pediatrics.

[7]  E. Shane,et al.  Immunosuppressive therapy and the skeleton , 1994, Trends in Endocrinology & Metabolism.

[8]  S. Epstein,et al.  The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. , 1994, Transplantation.

[9]  H. Mulder,et al.  Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. , 1994, British journal of rheumatology.

[10]  J. Kanis,et al.  Perspective : The diagnosis of osteoporosis , 1994 .

[11]  J. Eisman,et al.  Bone loss after heart transplantation: a prospective study. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  J. Visa,et al.  Bone fractures in liver transplant patients. , 1994, British journal of rheumatology.

[13]  R. Marcus,et al.  Osteopenia in adults with cystic fibrosis , 1994 .

[14]  D. Mancini,et al.  Osteoporosis and bone morbidity in cardiac transplant recipients. , 1994, The American journal of medicine.

[15]  R. Eastell,et al.  Measurement of bone mass and turnover. , 1993, Bailliere's clinical rheumatology.

[16]  I. Reid,et al.  Bone mineral density and body composition in adult patients with cystic fibrosis. , 1993, Thorax.

[17]  E. Shane,et al.  Osteoporosis after cardiac transplantation. , 1993, The American journal of medicine.

[18]  B. Kommerell,et al.  Bone disease after liver transplantation. , 1992, Transplantation proceedings.

[19]  G. Mudge,et al.  Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  R. Robinson,et al.  Estrogen and progesterone replacement therapy reduces glucocorticoid‐induced bone loss , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  Claus Christiansen,et al.  Diagnosis of Osteoporosis , 1992, Southern medical journal.

[22]  D. Carter,et al.  Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. , 1991, The Journal of clinical endocrinology and metabolism.

[23]  G. McCaughan,et al.  Bone loss after liver transplantation , 1991, Hepatology.

[24]  E. Dickson,et al.  Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis , 1991, Hepatology.

[25]  J. Udagawa,et al.  Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis. , 1991, The Journal of pediatrics.

[26]  R. Eastell,et al.  Classification of vertebral fractures , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  E. Dickson,et al.  Bone disease in liver transplant recipients: incidence, timing, and risk factors. , 1991, Transplantation proceedings.

[28]  L. Raisz,et al.  Glucocorticoid-induced osteoporosis: pathogenesis and management. , 1990, Annals of internal medicine.

[29]  T. Clemens,et al.  Skeletal disease in primary hyperparathyroidism , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  S. Epstein,et al.  The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. , 1989, Endocrinology.

[31]  S. Surachno,et al.  Bone repair in cyclosporin treated renal transplant patients. , 1989, Transplantation proceedings.

[32]  M. Boechat,et al.  Osteoporosis in cystic fibrosis. , 1988, The Journal of pediatrics.

[33]  M. Hodson,et al.  Vitamin D and parathyroid hormone and bone mineralisation in adults with cystic fibrosis. , 1988, Thorax.

[34]  I. Reid,et al.  PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD) , 1988, The Lancet.

[35]  M. Corey,et al.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. , 1988, Journal of clinical epidemiology.

[36]  J. Riancho,et al.  Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. , 1987, Thorax.

[37]  Brennan,et al.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. , 1987, Clinical chemistry.

[38]  P. Gallop,et al.  Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay. , 1985, Clinical chemistry.

[39]  M. McKenna,et al.  Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. , 1985, The Quarterly journal of medicine.

[40]  P. Delmas,et al.  SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS , 1984, The Lancet.

[41]  T. Chambers,et al.  Phagocytosis and trypsin‐resistant glass adhesion by osteoclasts in culture , 1979, The Journal of pathology.

[42]  T. Hahn,et al.  Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. , 1979, The Journal of pediatrics.